
In Vivo Base Editing for Neonatal Inborn Errors of Metabolism: Clinical Progress, N-of-1 Therapy, and the Ethics of Bespoke Genetic Medicine
<a href="https://news.google.com/rss/articles/CBMihwJBVV95cUxOS285eVozdEgzMlU4UEZ1UzZwVDl3MnZ3ZWZWa2pESF93c0hia080Ti12NGNSTWFHZnYxai1QWFNqWHRQVm4yZkFHOVJvS1o1Q2pQUFQ2eVo4TlNCajl2NWdoMVdZLU80N1JjdlR6SFFYWjh1SE16ckhGQ3RUODJndlBGSEFYb0FhWXJIazZHQjJENGdMWTVxc2tsckt1UVlIRlBKTEhKdUtScDVlOXcyRzJkX0dITmcyNmU3bTN0dWR6NzdwcDcyLVVTN0pqdXhmaF8zTFBNQkZid0xFdjlnZUlBSkozT2pmc2NYbnNBY0pRYUI5elF2R3lpMnMzOHl0aVJ6Si1mSQ?oc=5" target="_blank">In Vivo Base Editing for Neonatal Inborn Errors of Metabolism: Clinical Progress, N-of-1 Therapy, and the Ethics of Bespoke Genetic Medicine</a>&nbsp;&nbsp;<font color="#6f6f6f">Cureus</font>
